N. Anthony Coles, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 21,893 shares at $664.32 ($14.4M) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $14.4M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $651.36 | 300 | $195K | 1.4% |
| 2 | $652.95 | 1,101 | $719K | 5.0% |
| 3 | $652.95 | 1,101 | $719K | 5.0% |
| 4 | $653.31 | 800 | $523K | 3.6% |
| 5 | $653.31 | 800 | $523K | 3.6% |
| 6 | $655.14 | 403 |
| $264K |
| 1.8% |
| 7 | $655.14 | 403 | $264K | 1.8% |
| 8 | $656.48 | 1,400 | $919K | 6.4% |
| 9 | $657.53 | 835 | $549K | 3.8% |
| 10 | $657.53 | 835 | $549K | 3.8% |
| 11 | $658.65 | 935 | $616K | 4.3% |
| 12 | $658.65 | 935 | $616K | 4.3% |
| 13 | $659.00 | 300 | $198K | 1.4% |
| 14 | $660.78 | 448 | $296K | 2.1% |
| 15 | $660.78 | 448 | $296K | 2.1% |
| 16 | $661.56 | 3,344 | $2.2M | 15.3% |
| 17 | $661.56 | 3,344 | $2.2M | 15.3% |
| 18 | $662.55 | 3 | $2K | 0.0% |
| 19 | $663.73 | 905 | $601K | 4.2% |
| 20 | $663.73 | 905 | $601K | 4.2% |
| 21 | $664.32 | 1,174 | $780K | 5.4% |
| 22 | $664.32 | 1,174 | $780K | 5.4% |
| Total | $659.24 avg | 21,893 | $14.4M | 100% |
| Filing → |
| CERE | SELL | 2024-05-14 | $2.1M | — | Filing → |
| CERE | SELL | 2024-04-03 | $2.1M | — | Filing → |
| CERE | SELL | 2024-03-06 | $2.1M | — | Filing → |